Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5604)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2021 (publication date) through Jun 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i44/7582.htm |
| Number | Citing Articles |
| 1 |
Pilar Marcos, Rafael Coveñas. Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives. Applied Sciences 2023; 13(13): 7596 doi: 10.3390/app13137596
|
| 2 |
Alain Couvineau, Pascal Nicole, Valérie Gratio, Thierry Voisin. The Orexin receptors: Structural and anti-tumoral properties. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.931970
|
| 3 |
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, Alessandro Piergentili, Elizabeth Saab, Luca Botticelli, Carlo Cifani, Emanuela Micioni Di Bonaventura, Maria Vittoria Micioni Di Bonaventura, Wilma Quaglia. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders. Medicinal Research Reviews 2023; 43(5): 1607 doi: 10.1002/med.21959
|
| 4 |
Piyush Madaan, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Shivam Yadav, Satvinder Kaur, Saurabh Bhatia, Ahmed Al-Harrasi, Ahmed A. H. Abdellatif, Ghulam Md Ashraf, Mohamed M. Abdel-Daim, Hamad Ghaleb Dailah, Md Khalid Anwer, Simona Bungau. Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy. Neurotoxicity Research 2022; 40(2): 646 doi: 10.1007/s12640-022-00477-8
|
| 5 |
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Petr Jarolím, Dana Dlouhá, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Jan Piťha, Věra Adámková, Josef Kautzner. Attenuation of Hypocretin/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction. Journal of the American Heart Association 2023; 12(6) doi: 10.1161/JAHA.122.028987
|
| 6 |
Rahul Singh, Dalia A Biswas. Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review. Cureus 2023; doi: 10.7759/cureus.34009
|
| 7 |
Ruijie Jin, Shanbin Sun, Yang Hu, Hongfei Zhang, Xiangrong Sun. Neuropeptides Modulate Feeding via the Dopamine Reward Pathway. Neurochemical Research 2023; 48(9): 2622 doi: 10.1007/s11064-023-03954-4
|
| 8 |
Thierry Voisin, Pascal Nicole, Valérie Gratio, Anaïs Chassac, Dounia Mansour, Vinciane Rebours, Anne Couvelard, Alain Couvineau. The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.904327
|
| 9 |
Rengzheng Huan, Jiqin Zhang, Jianhe Yue, Sha Yang, Guoqiang Han, Yuan Cheng, Ying Tan. Orexin‐A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion. Journal of Cellular and Molecular Medicine 2024; 28(9) doi: 10.1111/jcmm.18318
|
| 10 |
Ana Laura Torres-Román, Karla Lucero Rodríguez-Flores, Víctor Manuel Hernández-Mora, Erika Ruiz-García, Oscar Prospero-García, Alberto Guijosa, Anayansi Molina, Marcela Morales-Mulia, Michael Aschner, Abel Santamaría, Alette Ortega-Gómez. Examining the Role of Histaminergic, Orexinergic, and Cannabinergic
Systems in Redox Regulation in Gastric Adenocarcinoma. Mini-Reviews in Medicinal Chemistry 2023; 23(18): 1806 doi: 10.2174/1389557523666230221104504
|
| 11 |
Haydn L. Ball, Hooda Said, Karen Chapman, Riqiang Fu, Yawei Xiong, Joshua A. Burk, Daniel Rosenbaum, Remi Veneziano, Myriam L. Cotten. Orexin A, an amphipathic α-helical neuropeptide involved in pleiotropic functions in the nervous and immune systems: Synthetic approach and biophysical studies of the membrane-bound state. Biophysical Chemistry 2023; 297: 107007 doi: 10.1016/j.bpc.2023.107007
|
| 12 |
Sherine Abdelmissih. A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System. Cureus 2022; doi: 10.7759/cureus.30788
|
| 13 |
Renzheng Huan, Jianhe Yue, Jinhai Lan, Jia Wang, Yuan Cheng, Jiqin Zhang, Ying Tan. Hypocretin-1 suppresses malignant progression of glioblastoma cells through Notch1 signaling pathway. Brain Research Bulletin 2023; 196: 46 doi: 10.1016/j.brainresbull.2023.03.006
|
| 14 |
Anna Costagliola, Luigi Montano, Emilia Langella, Renato Lombardi, Caterina Squillacioti, Nicola Mirabella, Giovanna Liguori. A Comparative Analysis of Orexins in the Physio-Pathological Processes of the Male Genital Tract: New Challenges? A Review. Veterinary Sciences 2024; 11(3): 131 doi: 10.3390/vetsci11030131
|